Fondazione Policlinico Universitario Policlinico Gemelli
Rome, Italy
Location status: Recruiting
NCT Number: NCT06926010
patients scheduled for carotid endoarterectomy will be randomly assigned to a group in which arterial hypotension will be avoided by a predictive haemodynamic approach or to a group in which arterial hypotension will be treated in a standard manner
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Rome, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
vasoactive drugs and fluids will be given based on the hypotension prediction index
Time frame: during surgery
we will compare the value of stump pressure between the two groups. the stump pressure will be measured after clamping the common and external carotid vessels
Interested in participating?
Request InfoFondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Effect of a Predictive Hemodynamic Approach on the Stump Pressure During Carotid Endoartectomy: a Randomized Controlled Trial
Acronym: PREST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07322913
Aortic Diseases, Arterial Occlusive Diseases
Hershey, Pennsylvania, United States
View Trial DetailsNCT04261478
Arterial Occlusive Diseases, Brain Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT07062471
Brain Diseases, Calcinosis
Little Rock, Arkansas, United States
View Trial DetailsNCT06276374
Brain Diseases, Cardiovascular Diseases
Seoul, South Korea
View Trial Details